nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—KCNMA1—artery—uterine cancer	0.0557	0.086	CbGeAlD
Bendroflumethiazide—KCNMA1—exocrine gland—uterine cancer	0.0485	0.075	CbGeAlD
Bendroflumethiazide—TPMT—myometrium—uterine cancer	0.0289	0.0447	CbGeAlD
Bendroflumethiazide—SLC12A3—renal system—uterine cancer	0.0283	0.0437	CbGeAlD
Bendroflumethiazide—KCNMA1—myometrium—uterine cancer	0.0269	0.0416	CbGeAlD
Bendroflumethiazide—CA2—exocrine gland—uterine cancer	0.0239	0.0369	CbGeAlD
Bendroflumethiazide—SLC12A3—female reproductive system—uterine cancer	0.0227	0.035	CbGeAlD
Bendroflumethiazide—TPMT—uterine cervix—uterine cancer	0.0225	0.0348	CbGeAlD
Bendroflumethiazide—TPMT—decidua—uterine cancer	0.0214	0.0331	CbGeAlD
Bendroflumethiazide—KCNMA1—epithelium—uterine cancer	0.0211	0.0326	CbGeAlD
Bendroflumethiazide—TPMT—renal system—uterine cancer	0.0211	0.0325	CbGeAlD
Bendroflumethiazide—TPMT—endometrium—uterine cancer	0.0204	0.0314	CbGeAlD
Bendroflumethiazide—KCNMA1—smooth muscle tissue—uterine cancer	0.0203	0.0314	CbGeAlD
Bendroflumethiazide—KCNMA1—decidua—uterine cancer	0.0199	0.0308	CbGeAlD
Bendroflumethiazide—TPMT—mammalian vulva—uterine cancer	0.0197	0.0304	CbGeAlD
Bendroflumethiazide—KCNMA1—renal system—uterine cancer	0.0196	0.0303	CbGeAlD
Bendroflumethiazide—KCNMA1—uterus—uterine cancer	0.0175	0.027	CbGeAlD
Bendroflumethiazide—KCNMA1—female reproductive system—uterine cancer	0.0157	0.0242	CbGeAlD
Bendroflumethiazide—TPMT—female gonad—uterine cancer	0.0153	0.0237	CbGeAlD
Bendroflumethiazide—TPMT—vagina—uterine cancer	0.0152	0.0235	CbGeAlD
Bendroflumethiazide—Blood disorder—Medroxyprogesterone Acetate—uterine cancer	0.015	0.0425	CcSEcCtD
Bendroflumethiazide—CA1—renal system—uterine cancer	0.0149	0.023	CbGeAlD
Bendroflumethiazide—Drug interaction—Progesterone—uterine cancer	0.0149	0.0422	CcSEcCtD
Bendroflumethiazide—Drug interaction—Medroxyprogesterone Acetate—uterine cancer	0.0135	0.0382	CcSEcCtD
Bendroflumethiazide—CA1—female reproductive system—uterine cancer	0.0119	0.0184	CbGeAlD
Bendroflumethiazide—CA4—renal system—uterine cancer	0.0116	0.018	CbGeAlD
Bendroflumethiazide—Vascular purpura—Progesterone—uterine cancer	0.0112	0.0318	CcSEcCtD
Bendroflumethiazide—Thirst—Progesterone—uterine cancer	0.0105	0.0299	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Medroxyprogesterone Acetate—uterine cancer	0.0104	0.0296	CcSEcCtD
Bendroflumethiazide—CA2—epithelium—uterine cancer	0.0104	0.0161	CbGeAlD
Bendroflumethiazide—Purpura—Progesterone—uterine cancer	0.0104	0.0295	CcSEcCtD
Bendroflumethiazide—CA2—smooth muscle tissue—uterine cancer	0.01	0.0155	CbGeAlD
Bendroflumethiazide—TPMT—lymph node—uterine cancer	0.00986	0.0152	CbGeAlD
Bendroflumethiazide—CA2—decidua—uterine cancer	0.00982	0.0152	CbGeAlD
Bendroflumethiazide—CA2—renal system—uterine cancer	0.00964	0.0149	CbGeAlD
Bendroflumethiazide—Thirst—Medroxyprogesterone Acetate—uterine cancer	0.00954	0.0271	CcSEcCtD
Bendroflumethiazide—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.00942	0.0267	CcSEcCtD
Bendroflumethiazide—CA4—female reproductive system—uterine cancer	0.00931	0.0144	CbGeAlD
Bendroflumethiazide—KCNMA1—lymph node—uterine cancer	0.00918	0.0142	CbGeAlD
Bendroflumethiazide—Cramp muscle—Progesterone—uterine cancer	0.00902	0.0256	CcSEcCtD
Bendroflumethiazide—CA2—mammalian vulva—uterine cancer	0.00902	0.0139	CbGeAlD
Bendroflumethiazide—CA4—female gonad—uterine cancer	0.00848	0.0131	CbGeAlD
Bendroflumethiazide—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00829	0.0235	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00826	0.0234	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.00817	0.0232	CcSEcCtD
Bendroflumethiazide—CA2—female reproductive system—uterine cancer	0.00772	0.0119	CbGeAlD
Bendroflumethiazide—CA2—female gonad—uterine cancer	0.00703	0.0109	CbGeAlD
Bendroflumethiazide—CA2—vagina—uterine cancer	0.00698	0.0108	CbGeAlD
Bendroflumethiazide—CA1—lymph node—uterine cancer	0.00697	0.0108	CbGeAlD
Bendroflumethiazide—Muscle spasms—Progesterone—uterine cancer	0.0058	0.0165	CcSEcCtD
Bendroflumethiazide—CA4—lymph node—uterine cancer	0.00545	0.00841	CbGeAlD
Bendroflumethiazide—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00525	0.0149	CcSEcCtD
Bendroflumethiazide—Blood disorder—Epirubicin—uterine cancer	0.00474	0.0134	CcSEcCtD
Bendroflumethiazide—Anorexia—Progesterone—uterine cancer	0.00469	0.0133	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Etoposide—uterine cancer	0.00461	0.0131	CcSEcCtD
Bendroflumethiazide—Hypotension—Progesterone—uterine cancer	0.0046	0.013	CcSEcCtD
Bendroflumethiazide—CA2—lymph node—uterine cancer	0.00452	0.00698	CbGeAlD
Bendroflumethiazide—Blood disorder—Doxorubicin—uterine cancer	0.00438	0.0124	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00437	0.0124	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Progesterone—uterine cancer	0.00428	0.0121	CcSEcCtD
Bendroflumethiazide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00425	0.0121	CcSEcCtD
Bendroflumethiazide—Constipation—Progesterone—uterine cancer	0.00421	0.0119	CcSEcCtD
Bendroflumethiazide—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00417	0.0118	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00388	0.011	CcSEcCtD
Bendroflumethiazide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00381	0.0108	CcSEcCtD
Bendroflumethiazide—Asthenia—Progesterone—uterine cancer	0.00353	0.01	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Dactinomycin—uterine cancer	0.00341	0.00966	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Progesterone—uterine cancer	0.00337	0.00955	CcSEcCtD
Bendroflumethiazide—Anorexia—Dactinomycin—uterine cancer	0.00332	0.00941	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Epirubicin—uterine cancer	0.0033	0.00937	CcSEcCtD
Bendroflumethiazide—Dizziness—Progesterone—uterine cancer	0.00326	0.00923	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Epirubicin—uterine cancer	0.00321	0.00911	CcSEcCtD
Bendroflumethiazide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.0032	0.00908	CcSEcCtD
Bendroflumethiazide—Vomiting—Progesterone—uterine cancer	0.00313	0.00888	CcSEcCtD
Bendroflumethiazide—Rash—Progesterone—uterine cancer	0.0031	0.0088	CcSEcCtD
Bendroflumethiazide—Dermatitis—Progesterone—uterine cancer	0.0031	0.0088	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Doxorubicin—uterine cancer	0.00306	0.00867	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00305	0.00866	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Dactinomycin—uterine cancer	0.00302	0.00858	CcSEcCtD
Bendroflumethiazide—Purpura—Epirubicin—uterine cancer	0.00298	0.00845	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Doxorubicin—uterine cancer	0.00297	0.00843	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Etoposide—uterine cancer	0.00297	0.00842	CcSEcCtD
Bendroflumethiazide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00295	0.00837	CcSEcCtD
Bendroflumethiazide—Nausea—Progesterone—uterine cancer	0.00292	0.00829	CcSEcCtD
Bendroflumethiazide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.00805	CcSEcCtD
Bendroflumethiazide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00281	0.00798	CcSEcCtD
Bendroflumethiazide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00281	0.00797	CcSEcCtD
Bendroflumethiazide—Purpura—Doxorubicin—uterine cancer	0.00276	0.00782	CcSEcCtD
Bendroflumethiazide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00265	0.00752	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Epirubicin—uterine cancer	0.00262	0.00744	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Epirubicin—uterine cancer	0.00261	0.00741	CcSEcCtD
Bendroflumethiazide—Asthenia—Dactinomycin—uterine cancer	0.0025	0.00708	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Etoposide—uterine cancer	0.00247	0.00699	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Epirubicin—uterine cancer	0.00243	0.0069	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00243	0.00688	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Doxorubicin—uterine cancer	0.00242	0.00686	CcSEcCtD
Bendroflumethiazide—Anorexia—Etoposide—uterine cancer	0.0024	0.00681	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Dactinomycin—uterine cancer	0.00238	0.00675	CcSEcCtD
Bendroflumethiazide—Hypotension—Etoposide—uterine cancer	0.00235	0.00667	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Doxorubicin—uterine cancer	0.00225	0.00639	CcSEcCtD
Bendroflumethiazide—Vomiting—Dactinomycin—uterine cancer	0.00221	0.00628	CcSEcCtD
Bendroflumethiazide—Rash—Dactinomycin—uterine cancer	0.00219	0.00622	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Etoposide—uterine cancer	0.00219	0.00621	CcSEcCtD
Bendroflumethiazide—Constipation—Etoposide—uterine cancer	0.00215	0.00611	CcSEcCtD
Bendroflumethiazide—Nausea—Dactinomycin—uterine cancer	0.00207	0.00586	CcSEcCtD
Bendroflumethiazide—Asthenia—Etoposide—uterine cancer	0.00181	0.00513	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Etoposide—uterine cancer	0.00172	0.00489	CcSEcCtD
Bendroflumethiazide—Dizziness—Etoposide—uterine cancer	0.00167	0.00472	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Epirubicin—uterine cancer	0.00166	0.00472	CcSEcCtD
Bendroflumethiazide—Vomiting—Etoposide—uterine cancer	0.0016	0.00454	CcSEcCtD
Bendroflumethiazide—Rash—Etoposide—uterine cancer	0.00159	0.0045	CcSEcCtD
Bendroflumethiazide—Dermatitis—Etoposide—uterine cancer	0.00159	0.0045	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Doxorubicin—uterine cancer	0.00154	0.00436	CcSEcCtD
Bendroflumethiazide—Nausea—Etoposide—uterine cancer	0.0015	0.00424	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Epirubicin—uterine cancer	0.00138	0.00392	CcSEcCtD
Bendroflumethiazide—Anorexia—Epirubicin—uterine cancer	0.00135	0.00382	CcSEcCtD
Bendroflumethiazide—Hypotension—Epirubicin—uterine cancer	0.00132	0.00374	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Doxorubicin—uterine cancer	0.00128	0.00363	CcSEcCtD
Bendroflumethiazide—Anorexia—Doxorubicin—uterine cancer	0.00124	0.00353	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Epirubicin—uterine cancer	0.00123	0.00348	CcSEcCtD
Bendroflumethiazide—Hypotension—Doxorubicin—uterine cancer	0.00122	0.00346	CcSEcCtD
Bendroflumethiazide—Constipation—Epirubicin—uterine cancer	0.00121	0.00342	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Doxorubicin—uterine cancer	0.00114	0.00322	CcSEcCtD
Bendroflumethiazide—Constipation—Doxorubicin—uterine cancer	0.00112	0.00317	CcSEcCtD
Bendroflumethiazide—Asthenia—Epirubicin—uterine cancer	0.00101	0.00287	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Epirubicin—uterine cancer	0.000966	0.00274	CcSEcCtD
Bendroflumethiazide—Asthenia—Doxorubicin—uterine cancer	0.000937	0.00266	CcSEcCtD
Bendroflumethiazide—Dizziness—Epirubicin—uterine cancer	0.000933	0.00265	CcSEcCtD
Bendroflumethiazide—Vomiting—Epirubicin—uterine cancer	0.000897	0.00255	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Doxorubicin—uterine cancer	0.000894	0.00254	CcSEcCtD
Bendroflumethiazide—Rash—Epirubicin—uterine cancer	0.00089	0.00252	CcSEcCtD
Bendroflumethiazide—Dermatitis—Epirubicin—uterine cancer	0.000889	0.00252	CcSEcCtD
Bendroflumethiazide—Dizziness—Doxorubicin—uterine cancer	0.000864	0.00245	CcSEcCtD
Bendroflumethiazide—Nausea—Epirubicin—uterine cancer	0.000838	0.00238	CcSEcCtD
Bendroflumethiazide—Vomiting—Doxorubicin—uterine cancer	0.00083	0.00236	CcSEcCtD
Bendroflumethiazide—Rash—Doxorubicin—uterine cancer	0.000823	0.00234	CcSEcCtD
Bendroflumethiazide—Dermatitis—Doxorubicin—uterine cancer	0.000823	0.00233	CcSEcCtD
Bendroflumethiazide—Nausea—Doxorubicin—uterine cancer	0.000776	0.0022	CcSEcCtD
